Department of Internal Medicine, Jeonbuk National University Hospital, Jeonju, Republic of Korea.
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
In Vivo. 2024 May-Jun;38(3):1405-1411. doi: 10.21873/invivo.13582.
BACKGROUND/AIM: The aging population has been growing gradually; therefore, the proportion of elderly patients undergoing colorectal endoscopic submucosal dissection (ESD) has also been increasing. However, there is a lack of large-scale studies on the efficacy and safety of colorectal ESD in elderly patients.
This retrospective analysis evaluated colorectal ESDs performed at five tertiary medical institutions between January 2015 and December 2020. Patients were categorized into the following four age groups: Middle-aged (<65 years), young-elderly (≥65 to <75 years), mid-elderly (≥75 to <85 years), and very elderly (≥85 years). Of the 1,446 patients included, 668 (46.2%), 466 (32.2%), 293 (20.3%), and 19 (1.3%) were in the middle-aged, young-elderly, mid-elderly, and very-elderly groups, respectively.
Compared to younger patients, more older patients used aspirin, clopidogrel, and anti-thrombotic agents. Additionally, the Charlson comorbidity index increased significantly with increasing age. However, no significant differences were observed in the complete resection rates nor the rates of complications, such as perforation, bleeding, and post-ESD coagulation syndrome, among the different age groups. A restricted cubic spline curve was used to construct predictive models for complete resection and major complications based on age and showed that the need for complete resection did not decrease with increasing age. Furthermore, major complications did not significantly differ with age progression.
Colorectal ESD should be actively considered as a relatively safe and effective treatment method for elderly patients.
背景/目的:人口老龄化逐渐加剧,因此,接受结直肠内镜黏膜下剥离术(ESD)的老年患者比例也在增加。然而,关于老年患者结直肠 ESD 的疗效和安全性,缺乏大规模研究。
本回顾性分析评估了 2015 年 1 月至 2020 年 12 月五家三级医疗机构进行的结直肠 ESD。患者分为以下四个年龄组:中年(<65 岁)、年轻老年人(≥65 岁至<75 岁)、中年老年人(≥75 岁至<85 岁)和非常老年人(≥85 岁)。在 1446 例患者中,分别有 668(46.2%)、466(32.2%)、293(20.3%)和 19(1.3%)例患者为中年、年轻老年人、中年老年人和非常老年人。
与年轻患者相比,更多老年患者使用阿司匹林、氯吡格雷和抗血栓药物。此外,随着年龄的增长,Charlson 合并症指数显著增加。然而,不同年龄组之间的完全切除率以及穿孔、出血和 ESD 后凝血综合征等并发症的发生率没有显著差异。使用限制立方样条曲线基于年龄构建完全切除和主要并发症的预测模型,结果表明,完全切除的需求并未随年龄增长而降低。此外,主要并发症与年龄进展无显著差异。
结直肠 ESD 应积极考虑作为老年患者安全有效的治疗方法。